IP Library Granted Patent US 8,354,119
Granted Patent B2
US 8,354,119 · App. 10/299,008 · Granted Jan 15, 2013

Resorbable extracellular matrix containing collagen I and collagen II for reconstruction of cartilage

Inventors: Peter Geistlich (Stansstad, CH); Lothar Schloesser (Darmstadt, DE)
Assignee: ED. Geistlich Soehne AG Fuer Chemische Industrie
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,354,119
App. No.
10/299,008
Granted
Jan 15, 2013
Kind
B2
Abstract

A resorbable extracelluar matrix for reconstruction of cartilage tissue includes a mixture of collagen I and collagen II in a respective ratio of from about 1:19 to 19:1. The matrix can be utilized as a scaffold implant for vertebral or meniscal cartilage regeneration.

Claims (20)

1. A resorbable extracellular matrix for reconstruction of cartilage tissue, said matrix comprising collagen material comprising a mixture of collagen I and collagen II in a respective ratio of from 1:19 up to 25:75, wherein said matrix is prepared by mixing a slurry of collagen I and a slurry of collagen II to form a mixed slurry of collagen I and collagen II in said respective ratio, and drying said mixture, wherein said mixture is partially cross-linked by UV irradiation, or said mixture is partially cross-linked by heating said mixture to a temperature of at least about 100° C. and up to about 140° C., wherein said mixture is partially cross-linked over a time period of from about 30 minutes up to about 8 hours.

2. The matrix of claim 1 wherein said collagen I and collagen II are derived from natural cartilage tissue from which non-collagen proteins have been removed, and wherein said matrix comprises fibres of native collagen I and collagen II which are physiologically acceptable for implant into a mammalian body.

3. The matrix of claim 1 wherein said matrix has a pore size in a range of about 50 to 400 μM.

4. The matrix of claim 3 having a pore size in a range of about 70 to 120 μm.

5. The matrix of claim 1 containing at least one glycosaminoglycan in an amount comprising about 1 to 15% by weight of said matrix.

6. The matrix of claim 5 wherein said at least one glycosaminoglycan is present in an amount comprising about 2 to 3% by weight of said matrix.

7. The matrix of claim 1 which includes at least one material selected from the group consisting of glycosaminoglycans, chondronectin, anchorin II, cartilage inducing factor, insulin-like growth factor, transforming growth factor β and mixtures thereof.

8. The matrix of claim 7 wherein said glycosaminoglycan is selected from chondroitin sulphate, keratan sulphate, dermatan sulphate, hyaluronic acid and mixtures thereof.

9. The matrix of claim 2 wherein said natural cartilage tissue has been subjected to defatting.

10. The matrix of claim 1 wherein said collagen I and said collagen II are from pig.

11. The matrix of claim 1 wherein said collagen I and said collagen II are in a respective ratio of about 1:9.

12. The matrix of claim 1 wherein the mixture is partially cross-linked by UV irradiation for up to about 8 hours.

13. The matrix of claim 1 wherein the mixture is partially cross-linked by heating the mixture to between about 100-120° C. for from about 30 minutes to about 5 hours.

14. The matrix of claim 1 wherein the mixture is partially cross-linked by heating the mixture to between about 110-130° C.

15. The matrix of claim 1 , wherein the mixture is dried by freezing the mixture, and lyophilizing the frozen mixture.

16. The matrix of claim 15 wherein the lyophized mixture is crosslinked by heating the mixture to about 120-140° C. for at least about 2 hours, and then the mixture is cut and stamped to a desired thickness and shape.

17. The matrix of claim 1 wherein said matrix comprises a fleece.

18. An implant for promoting cartilage regeneration comprising a matrix as claimed in claim 1 , said implant having a thickness of about 0.2 to 2 cm.

19. The implant of claim 18 having a thickness of about 0.4 to 1 cm.

20. The implant of claim 18 wherein said matrix is a carrier of a material selected from mesenchymal stem cells and a cartilage cell growth-promoting nucleic acid sequence.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 3, 2003
From: GEISTLICH, PETER; SCHLOESSER, LOTHAR
To: ED. GEISTLICH SOEHNE AG FUER CHEMISCHE INDUSTRIE
Reel/Frame 013629/0409 →
Continuity (2)
Provisional Application 60331618 · Nov 20, 2001
Related Publication 20030095994A1 · May 22, 2003